Optimizing Infliximab Use in Real-World Inflammatory Bowel Disease: Insights from a Population Pharmacokinetic Model Integrating Intravenous and Subcutaneous Formulations
- Author:
Sung Hoon JUNG
1
;
Sang-Bum KANG
Author Information
- Publication Type:Editorial
- From:Gut and Liver 2025;19(3):299-300
- CountryRepublic of Korea
- Language:English
